title: Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study.
abstract: The safety and effectiveness of tetrabenazine in different sub-populations of Huntington disease (HD) is not known. In this study, we evaluated the safety of tetrabenazine in individuals on an antidepressant and its effectiveness in advanced HD. Tetrabenazine was not associated with an increased incidence of depressed mood among those taking antidepressants and was effective at reducing chorea in those with advanced HD.
authors.affiliation: Neurologist, Johns Hopkins University;  Department of Neurology, University of Rochester, Rochester, NY, USA;  University of Rochester Medical Center, Rochester NY;  Movement Disorders Fellow, Johns Hopkins University;  Partner, KM Pharmaceutical Consulting;  Associate Professor of Neurology, University of Rochester School of Medicine and Dentistry;  Professor of Neurology, Pharmacology & Human Science. Director, Program for Regulatory Science & Medicine (PRSM) and  Doctor.
authors.forename: Ray
authors.initials: R
authors.lastname: Dorsey
authors.forename: Kevin
authors.initials: K
authors.lastname: Biglan
authors.forename: Shirley
authors.initials: S
authors.lastname: Eberly
authors.forename: Peggy
authors.initials: P
authors.lastname: Auinger
authors.forename: Alicia
authors.initials: A
authors.lastname: Brocht
authors.forename: Chizoba C
authors.initials: CC
authors.lastname: Umeh
authors.forename: David
authors.initials: D
authors.lastname: Oakes
authors.forename: Kathleen
authors.initials: K
authors.lastname: Clarence-Smith
authors.forename: Frederick
authors.initials: F
authors.lastname: Marshall
authors.forename: Ira
authors.initials: I
authors.lastname: Shoulson
authors.forename: Samuel
authors.initials: S
authors.lastname: Frank